🔎 Trials Near Me

Почетна › Рак дојке › Јута › Salt Lake City

Kliničke studije za Рак дојке u gradu Salt Lake City, UT

27 studija za Рак дојке traži učesnike na lokacijama u gradu Salt Lake City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Тражи се учесникФаза 1/2
  • Research Facility, Salt Lake City
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT06590857

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Тражи се учесникФаза 3
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Тражи се учесникФаза 3
  • Utah Cancer Specialists, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Тражи се учесникФаза 3
  • Huntsman Cancer Hospital at the University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06790693

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Тражи се учесникФаза 2
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Жене · Ажурирано 4. 11. 2026. · NCT07287098

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3
  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • Farmington Health Center, Farmington · 15 ми удаљено
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Тражи се учесникФаза 1/2
  • University of Utah Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07100106

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Тражи се учесникФаза 3
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Тражи се учесникФаза 3
  • Clinical Trial Site, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07085767

Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu

Тражи се учесникФаза 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT07203378

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Тражи се учесникФаза 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06500481

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Тражи се учесникФаза 3
  • University of Utah - Huntsman Cancer Institute, Salt Lake City
Узраст од 18 до 100 · Оба пола · Ажурирано 6. 8. 2026. · NCT05232916

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Тражи се учесникФаза 1/2
  • Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT05377996

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Тражи се учесникФаза 2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 6. 5. 2026. · NCT01042379

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Тражи се учесник
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT05297734

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Тражи се учесникФаза 3
  • Utah Cancer Specialists-Salt Lake City, Salt Lake City
  • LDS Hospital, Salt Lake City
Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Тражи се учесникФаза 1/2
  • START Center for Cancer Care - Mountain Region, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 27. 3. 2026. · NCT06395519

Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System

Тражи се учесникРана фаза 1
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Узраст 18 и старији · Жене · Ажурирано 17. 3. 2026. · NCT05291507

Improving Care for Rural Patients With Solid Tumors

Тражи се учесник
  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 2. 2026. · NCT04916990

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

Тражи се учесникФаза 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Узраст 18 и старији · Жене · Ажурирано 9. 12. 2025. · NCT06961955

SAVE Trial: SAfe Opioid Use Video Education

Тражи се учесник
  • University of Utah Huntsman Cancer Institute, Salt Lake City
Узраст 18 и старији · Жене · Ажурирано 26. 11. 2025. · NCT07044583

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

Тражи се учесникЗдраве особе су добродошле
  • Huntsman Cancer Institute/ University of Utah, Salt Lake City
Узраст 18 и старији · Жене · Ажурирано 21. 11. 2025. · NCT07029490

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Salt Lake City
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

Тражи се учесникФаза 3
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 3. 10. 2025. · NCT07166042

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Тражи се учесникФаза 1
  • University of Utah- Huntsman Cancer Center, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2025. · NCT05216432

Community Services Navigation to Advance Health Equity in Breast Cancer Screening

Тражи се учесник
  • University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences, Salt Lake City
Узраст 18 и старији · Оба пола · Ажурирано 1. 8. 2025. · NCT06305312

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu Salt Lake City

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.